Old Web
English
Sign In
Acemap
>
Paper
>
CD3-CD16+ (NK) cells are rapidly and markedly affected by interferon β 1b (INFβ1b) therapy in relapsing-remitting MS patients
CD3-CD16+ (NK) cells are rapidly and markedly affected by interferon β 1b (INFβ1b) therapy in relapsing-remitting MS patients
1998
A.M. Ferrarini
Paola Perini
S. Sivieri
P. Bulian
Giovanni Biasi
P. Gallo
Keywords:
Diabetes mellitus
Immunology
CD16
Interferon
CD3
Biology
relapsing remitting
interferon β 1b
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]